Researchers from Lawrence Berkeley National Laboratory report that they have developed a novel approach to advance the development of bacteriophages to combat antibiotic resistance.
“We developed a high-throughput genetic screening approach that can identify the part of the bacterial cell targeted by a potent type of phage weapon called ‘single-gene lysis proteins,’” explains Vivek Mutalik, co-senior author of the study published in Nature Chemical Biology last month. “With rising antibiotic resistance, we urgently need antibiotic alternatives. Some of the smallest phages that we know of code for single-gene lysis proteins (Sgls), also known as protein antibiotics, to inhibit key components of bacterial cell wall production that, when disrupted, consistently kill the cell.”
There appears to be at least one type of phage for every known strain of bacteria, and they are thought to be the most abundant biological entities on Earth. This massive abundance, specificity, and efficacy means that there are plenty around to study, and that we should theoretically be able to use phages to control any harmful microbe. The problem arises when trying to isolate a single phage from the environment and determine which microbe it targets and how. Scientists are often unable to assess phage-bacteria battles based on genomic sequence alone or study them in action because many bacteria can’t be cultured in a lab—and even if they could, there’s an inherent catch-22 of needing to know ahead of time which bacteria to culture in order to study the phages that infect and kill them.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
To sidestep these obstacles and identify the cellular targets of Sgls, Mutalik and his colleagues used Dual-Barcoded Shotgun Expression Library Sequencing (Dub-seq). Dub-seq allows scientists to employ a coded library of DNA fragments to investigate how unknown genes function, and can be applied to complicated environmental samples that contain the DNA of many organisms—no culturing needed.
In this study, the authors used six Sgls from six phages that infect different bacteria and identified the part of the bacterial cell wall or supporting molecules that each Sgl attacks. In collaboration with scientists from Texas A&M University, they conducted a detailed characterization of the function of one Sgl.
This work showed that the Sgl proteins target pathways for cell wall building that arose very early in the evolutionary history of bacteria and are still used by nearly all bacteria (including pathogenic bacteria). Since the Sgl proteins attack such fundamental and ubiquitous targets, they can kill bacteria other than the phage’s target strain—confirming they have great potential as antibiotics.
"Phages are extraordinary innovators when it comes to destroying bacteria. We're really excited to uncover novel bacterial pathogen-targeting mechanisms that could be leveraged into therapies,” adds first author Benjamin Adler.